Saturday, 5 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 4, 2026

The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet

View original at globenewswire.com
The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet Washington, D.C., April 04, 2026 (GLOBE NEWSWIRE) -- There is a specific kind of dread that comes from learning a threat was already present before any symptoms appea…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The evidence of a coming AI market collapse is already present in the balance sheets, financing arrangements, insider behavior, and structural fragilities of the AI sector

    60% confidence
  • The collapse has already started behind the scenes

    60% confidence
  • In January 2020, issued CONTAGION note predicting a pandemic-driven market panic three weeks before stocks suffered the fastest crash in history

    60% confidence
  • This is not a prediction, it is an observation - describing what is already happening, visible to anyone with access to the right data points

    60% confidence
  • The company at the center of the AI financial system is showing the same distress signals Lehman showed weeks before its failure

    60% confidence
  • In 2008, warned that financial catastrophe was imminent three weeks before Lehman Brothers collapsed

    60% confidence
  • The CFO of the AI company identified as central failure point has implied publicly that a government bailout may be required

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
The Doctor Who Sees the X-Ray Before the Patient Feels the Pain: Jim Rickards Says the AI Tumor Is Already There — Most People Just Haven't Been Told Yet — Source | Via News | ViaNews EU